Stocks and Investing Stocks and Investing
Tue, June 25, 2024

Raghuram Selvaraju Maintained (TRDA) at Strong Buy with Decreased Target to $18 on, Jun 25th, 2024


Published on 2024-10-28 12:05:31 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Entrada Therapeutics, Inc." (TRDA) at Strong Buy with Decreased Target from $20 to $18 on, Jun 25th, 2024.

Raghuram, nor any peers, have made any analyst calls on TRDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources